Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Frontiers in Medicine|February 26, 2021
Causes of Pruritus in Patients Treated With Immune Checkpoint Inhibitors for Melanomas or Skin CarcinomasNadia Salinas, Emmanuel Nowak, Maxime Etienne, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 12, 2020
PD-L1 Copy Number Variation Does Not Correlate With PD-L1 Expression or Response to Anti-PD-1 Immunotherapy In Patients With Advanced MelanomasJérémy Pérottet, Emeline Le Goff, Delphine Legoupil, et al.
Dermatology (Basel, Switzerland)|February 10, 2021
Teledermatology in Times of COVID-19 Confinement: Comparing Patients' and Physicians' Satisfaction by the Standardized Brest Teledermatology QuestionnaireJoachim W Fluhr, Annie Gueguen, Delphine Legoupil, et al.
Clinical Case Reports|July 1, 2021
Laparoscopy-assisted immediate vaginal reconstruction with a vertical pedicled deep inferior epigastric perforator flap for primary melanoma of the vaginaPierre-François Dupré, Delphine Legoupil, Camille Vigouroux, et al.
Journal of Cancer Research and Clinical Oncology|June 11, 2021
The prognostic significance of PD-L1 expression on tumor and immune cells in Merkel cell carcinomaMorgan Guénolé, Paolo Bénigni, Vincent Bourbonne, et al.
Acta Oncologica (Stockholm, Sweden)|October 14, 2022
Immune checkpoint inhibitors in patients aged 80 or older with advanced non-small cell lung cancer or melanoma: a real-life multicentre studySoraya Benguerfi, Thierry Lesimple, Roch Houot, et al.
EJNMMI Physics|December 7, 2023
Clinical application of a population-based input function (PBIF) for a shortened dynamic whole-body FDG-PET/CT protocol in patients with metastatic melanoma treated by immunotherapyMathieu Pavoine, Philippe Thuillier, Nicolas Karakatsanis, et al.
Melanoma Research|February 13, 2025
MHC class II: a predictor of outcome in melanoma treated with immune checkpoint inhibitorsKarim Amrane, Pierre Le Noac'h, Patrice Hemon, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 16, 2026
Prognostic value of TMTV and Dmax calculated from <sup>18</sup>F-fluorodeoxyglucose positron emission tomography images in metastatic cutaneous melanoma treated with immune checkpoint blockadeKarim Amrane, Bastien Cabarrou, Coline Le Meur, et al.
Cancers|August 26, 2022
Impact of Distribution of a Tip Sheet to Increase Early Detection and Prevention Behavior among First-Degree Relatives of Melanoma Patients: A Randomized Cluster TrialDiane Marcé, Floriane Le Vilain-Abraham, Morgiane Bridou, et al.
Pageof 4